301. 黄斑ジストロフィー Macular dystrophy Clinical trials / Disease details

臨床試験数 : 46 / 薬物数 : 42 - (DrugBank : 11) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 67

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00420602 (ClinicalTrials.gov)	September 21, 2007	10/1/2007	DHA Supplementation in Patients With STGD3	Clinical Interventions Against Stargardt Macular Dystrophy: DHASupplementation in Patients With STGD ...	Dominantly Inherited Stargardt's Disease (STGD3)	Dietary Supplement: Over the counter DHA/EPA dietary supplementation	University of Utah	NULL	Completed	18 Years	105 Years	All	11	N/A	United States
2	NCT00060749 (ClinicalTrials.gov)	May 5, 2003	9/5/2003	Effect of DHASupplements on Macular Function in Patients With Stargardt Macular Dystrophy and Starga ...	Investigation of the Effect of Dietary Docosahexaenoic Acid (DHA) Supplementation on Macular Functio ...	Macular Degeneration	Drug: Docosahexaenoic Acid (DHA) Dietary Supplement	National Eye Institute (NEI)	NULL	Completed	N/A	N/A	All	22	Phase 1	United States

First Previous1Next Last